Updates from The Motley Fool

Latest updates on Pfizer from Fool.com.

Stock Performance

PFE vs. S&P 500 | 2 Year Performance
PFE 1-Day Stock Chart
PFE 5-Day Stock Chart
PFE 1-Month Stock Chart
PFE 3-Month Stock Chart
PFE 6-Month Stock Chart
PFE 1-Year Stock Chart
PFE 2-Year Stock Chart
PFE 5-Year Stock Chart
View Interactive PFE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Pfizer.
Current Price: $33.40
Prev Close: $33.70
Open: $33.67
Bid: $33.43
Ask: $33.58
Day's Range: $33.33 - $33.90
52wk Range: $28.25 - $36.46
Volume: 36,063,492
Avg Vol 52,131,283
Market Cap: $206.18B
P/E (ttm): 30.36
EPS (ttm): $1.11
Div & Yield: $1.20 (3.6%)

Company Rating

What our community thinks about Pfizer.
CAPS Rating 4 out of 5
5539 Outperform
578 Underperform
CAPS All Stars
1405 Outperform
85 Underperform

How do you think Pfizer will perform against the market?

You pick for Pfizer is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ian Read, CEO

85% Approve

Based on 568 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Pfizer.

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers